SERV vs VRTX · rev $1.8M vs P/E 30, rev $12.00B
Serve Robotics Inc. Common Stock (SERV) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Serve Robotics Inc. Common Stock (SERV) is a specialty industrial machinery company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported SERV revenue for 2024-12-31 was $1.8M. Net income was -$39.2M. Revenue was up 773.3% from 2023-12-31 to 2024-12-31. SERV currently screens at market cap $614.4M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
SERV currently screens at market cap $614.4M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the SERV and VRTX stock pages for the full models.
Not investment advice.